Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.

A Brand1, F H Claas, P J Voogt

  • 1Department of Immunohematology, University Medical Center, Leiden, The Netherlands.

Vox Sanguinis
|January 1, 1988
PubMed
Summary

Alloimmunization developed in 21% of patients receiving blood transfusions. Only 9% required HLA-matched platelets, but previous pregnancies increased refractoriness risk in females.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of Routine Pelvic Examination in the Follow-Up of Patients Receiving Adjuvant Radiation Therapy for Endometrial Cancer: An Australian Tertiary-Centre Experience.

Journal of medical imaging and radiation oncology·2025
Same author

Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells.

Journal of dental research·2024
Same author

Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI).

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

Informed Consent before coronary angiography and percutaneous coronary intervention from the patient's perspective: A picture is worth a thousand words.

International journal of cardiology. Heart & vasculature·2022
Same author

Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Same author

A nurse- and peer-led psycho-educational intervention to support women with gynaecological cancers receiving curative radiotherapy: The PeNTAGOn randomised controlled trial - ANZGOG 1102.

Gynecologic oncology·2020

Area of Science:

  • Transfusion Medicine
  • Immunology

Background:

  • Alloimmunization is a significant concern in patients requiring repeated blood transfusions.
  • Understanding alloantibody development is crucial for optimizing transfusion strategies.

Purpose of the Study:

  • To investigate the incidence and course of alloimmunization following leukocyte-depleted red cell and random donor platelet transfusions.
  • To identify patient factors associated with alloantibody development and platelet refractoriness.

Main Methods:

  • Prospective study of 335 patients with negative antibody screening and transfusion history.
  • Monitoring for lymphocytotoxic and multispecific alloantibodies.
  • Comparison of antibody development and platelet refractoriness between patient groups.

Related Experiment Videos

Main Results:

  • 21% of patients developed lymphocytotoxic antibodies (transient or permanent).
  • 9% developed multispecific alloantibodies requiring HLA-matched platelets.
  • Previous pregnancies increased platelet refractoriness in females (p < 0.001).
  • No significant difference in antibody development between leukemia and aplastic anemia patients.

Conclusions:

  • Leukocyte-depleted blood products reduce but do not eliminate alloimmunization risk.
  • Multispecific alloantibodies necessitating HLA-matched platelets occur in a minority of patients.
  • Female parity is a significant risk factor for platelet refractoriness.